Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Laxante Fibra
- Development stage
- Unknown
- Lead developer
- Geiser Pharma
- Administration
- Oral
01
Overview
Laxante Fibra is a bulk-forming fiber laxative formula developed by the Spanish pharmaceutical company GeiserPHARMA SL. It is designed for the treatment of occasional or functional constipation. The product functions as a bulk-forming agent, which absorbs water in the intestine to create a softer, bulkier stool that stimulates normal bowel movements. In clinical development, it was evaluated in a multisite, randomized Phase 3 trial in Spain, where its efficacy and safety were compared against Plantaben (a psyllium husk-based laxative), focusing on endpoints such as weekly stool frequency and time to first response.
- Brand names
- Laxante Fibra
- Other names
- fiber laxativeGeiserPHARMA fiber laxative
Beyond the preview
Go deeper on Laxante Fibra.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laxante Fibra.